ArticleOpen forum infectious diseases2023

Impact of Obesity on the Drug-Drug Interaction Between Dolutegravir and Rifampicin or Any Other Strong Inducers.

Mattia Berton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.